ENVIVA INC (EVA) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:EVA - US29415B1035 - Common Stock
0.4198 USD
+0.01 (+2.22%)
ChartMill assigns a Buy % Consensus number of 45% to EVA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.08. This target is 871.89% above the current price.
EVA was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about EVA.
In the previous month the buy percentage consensus was at a similar level.
EVA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-21 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-11-16 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2023-11-10 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-11-10 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2023-10-18 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-10-04 | Truist Securities | Maintains | Sell -> Sell |
| 2023-10-03 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2023-10-03 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-07-11 | Citigroup | Maintains | Buy -> Buy |
| 2023-05-15 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-05-05 | Raymond James | Maintains | Strong Buy |
| 2023-05-04 | Truist Securities | Downgrade | Buy -> Sell |
| 2023-04-05 | Raymond James | Maintains | Strong Buy |
| 2023-04-05 | Citigroup | Maintains | Buy |
| 2023-04-04 | Truist Securities | Maintains | Buy |
| 2023-04-04 | Citigroup | Maintains | Buy |
| 2023-03-03 | JP Morgan | Maintains | Neutral |
| 2023-03-02 | Raymond James | Maintains | Strong Buy |
| 2023-02-01 | Truist Securities | Maintains | Buy |
| 2022-11-29 | RBC Capital | Maintains | Sector Perform |
| 2022-10-20 | JP Morgan | Maintains | Neutral |
| 2022-10-18 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2022-10-14 | Citigroup | Upgrade | Neutral -> Buy |
| 2022-09-15 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2022-08-19 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2022-07-20 | JP Morgan | Maintains | Neutral |
| 2022-05-13 | RBC Capital | Maintains | Outperform |
| 2022-04-19 | JP Morgan | Maintains | Neutral |
| 2022-03-07 | RBC Capital | Maintains | Outperform |
| 2022-03-02 | JP Morgan | Maintains | Neutral |
ENVIVA INC / EVA FAQ
What is the average price target for ENVIVA INC (EVA) stock?
8 analysts have analysed EVA and the average price target is 4.08 USD. This implies a price increase of 871.89% is expected in the next year compared to the current price of 0.4198.
What is the consensus rating for EVA stock?
The consensus rating for ENVIVA INC (EVA) is 45 / 100 . This indicates that analysts generally have a neutral outlook on the stock.